XML 33 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
INCOME TAXES
12 Months Ended
Dec. 31, 2015
Income Taxes  
INCOME TAXES

No provision or benefit for federal or state income taxes has been recorded because the Company has incurred a net loss for all periods presented and has provided a valuation allowance against its deferred tax assets. A provision for minimum state income taxes of $3,420 has been recorded for the year ended December 31, 2015.

 

At December 31, 2015 and 2014, the Company had gross federal net operating loss carryforwards of approximately $105,024,000 and $98,462,000, respectively, which begin expiring in 2018. The Company had gross state net operating loss carryforwards of approximately $59,243,000 and $52,684,000, respectively which began to expire in 2015. The Company also had federal and state research and development tax credit carryforwards of approximately $3,122,000 which will begin to expire in 2018. The United States Tax Reform Act of 1986 contains provisions that may limit the Company’s net operating loss carryforwards available to be used in any given year in the event of significant changes in the ownership interests of significant stockholders, as defined in Internal Revenue Section 382. The effect of an ownership change would be the imposition of an annual limitation on the use of NOL carryforwards attributable to periods before the change. The amount of the annual limitation depends upon the value of the Company immediately before the change, changes to the Company’s capital during a specified period prior to the change, and the federal published interest rate. The Company has not completed an evaluation of whether Section 382 would impact the gross NOLs.

 

Significant components of the Company’s net deferred tax asset are as follows:

 

    December 31,  
    2015     2014  
Deferred Tax Assets/(Liabilities):                
Net operating loss carryforwards   $ 38,836,000     $ 34,500,000  
Research credit carryforwards     3,122,000       3,048,000  
Acquired intangible assets, net           (3,697,000 )
Restricted stock and warrants     479,000       731,000  
Other temporary differences     92,000       50,000  
 Total deferred tax assets, net     42,529,000       34,632,000  
Valuation allowance     (42,529,000 )     (34,632,000 )
Net deferred tax asset   $     $  

 

The Company has maintained a full valuation allowance against its deferred tax items in both 2015 and 2014. A valuation allowance is required to be recorded when it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Since the Company cannot be assured of realizing the net deferred tax asset, a full valuation allowance has been provided.  In the years ended December 31, 2015 and 2014, the valuation allowance increased by $7,897,000 and $2,773,000, respectively.

 

The Company has no uncertain tax positions as of December 31, 2015 and 2014 that would affect its effective tax rate. The Company does not anticipate a significant change in the amount of unrecognized tax benefits over the next twelve months. Because the Company is in a loss carryforward position, the Company is generally subject to US federal and state income tax examinations by tax authorities for all years for which a loss carryforward is available. If and when applicable, the Company will recognize interest and penalties as part of income tax expense.

 

Income taxes computed using the federal statutory income tax rate differs from the Company’s effective tax rate primarily due to the following:

 

    Years Ended December 31,  
    2015     2014  
    %     %  
Income taxes benefit (expense) at statutory rate                                                                                          34.00       34.00  
State income tax, net of federal benefit                                                                                          (0.01 )     2.76  
Permanent Differences:                
Financing loss                                                                                       (7.23 )      
Non-cash interest expense warrant     (0.50 )     (8.07 )
Gain/loss or revaluation of derivative warrant liability     0.12       2.07  
Stock-based compensation expense                                                                                       (2.40 )     (0.88 )
Other                                                                                       (0.04 )     0.01  
R&D credits                                                                                          0.49       1.21  
Change in valuation allowance                                                                                          (24.45 )     (31.13 )
      (0.02 )     (0.03 )